CDC Leadership Vacuum: Experts Warn of Public Health Risks | Healio News

CDC Leadership Vacuum: Experts Warn of Public Health Risks | Healio News

March 18, 2026 Ananya Mittal - World Editor News

The United States faces heightened public health risks with the continued absence of a permanent director at the Centers for Disease Control and Prevention (CDC), according to health experts. For 13 of the last 14 months, the agency has operated without Senate-confirmed leadership, a situation some officials say compromises its ability to respond effectively to emerging health threats.

Currently, National Institutes of Health (NIH) Director Jay Bhattacharya, MD, PhD, is serving as acting director of the CDC, a dual role that raises concerns about bandwidth and on-site leadership. This arrangement began in February, following the nomination of previous acting director Jim O’Neill to head the National Science Foundation. The ongoing turnover at the CDC, a globally respected public health agency, has prompted warnings about potential vulnerabilities in the nation’s preparedness and response capabilities.

A Demanding Dual Role

While the White House has expressed confidence in both Bhattacharya and O’Neill, former CDC officials question the feasibility of effectively leading two major agencies simultaneously. Debra Houry, MD, MPH, who resigned as the CDC’s chief medical officer last summer, emphasized the all-consuming nature of both positions. “Both are 24/7 roles and in different cities,” Houry stated. “This continues the lack of onsite leadership for CDC and puts all of us at risk if our federal public health agency isn’t ready for the next health threat.”

The logistical challenges are significant. According to the Wall Street Journal, Bhattacharya intends to visit the CDC’s Atlanta campus weekly, but the practicalities of dividing time between Atlanta and the NIH in Bethesda, Maryland, remain a concern.

The Vacancy and its Implications

The lack of a permanent director isn’t simply an administrative issue; it strikes at the core of the CDC’s mission. Tom Frieden, MD, MPH, a former CDC director during the Obama administration, outlined the critical responsibilities of the role: leading the agency to protect Americans from health threats, upholding scientific integrity, and communicating clearly with the public. “Those functions are essential to keep Americans safe,” he said.

The situation is further complicated by recent changes in the CDC’s leadership structure and decision-making processes. Last summer, the abrupt firing of Susan Monarez, PhD, as CDC director after just 29 days in the role, raised questions about the administration’s commitment to scientific expertise. The subsequent appointment of O’Neill, a former biotech investor, likewise drew scrutiny.

The Vacancies Reform Act limits the duration of temporary appointments in executive branch positions to 210 days without Senate confirmation. O’Neill’s tenure would have reached this limit by the end of March, further underscoring the need for a permanent replacement. However, a novel requirement for Senate confirmation adds another layer of complexity to the process.

Shifting Influence and Decision-Making

The absence of a permanent director has led to a shift in decision-making authority, with HHS Secretary Robert F. Kennedy Jr., O’Neill, and CDC Chief of Staff Matthew Buzzelli taking on responsibilities traditionally handled by the agency’s leader. This includes signing off on recommendations from the Advisory Committee on Immunization Practices (ACIP), which has itself undergone changes under Kennedy’s leadership.

In January, HHS made unprecedented changes to the CDC childhood vaccine schedule without input from the ACIP, a move that sparked criticism from public health experts. A scheduled ACIP meeting in February was abruptly canceled and rescheduled, raising further questions about the committee’s future influence.

A Leadership Vacuum?

The current situation has led some to describe the CDC as operating in a “leadership vacuum.” Anne Schuchat, MD, former CDC principal deputy director, emphasized the importance of having a designated leader representing the agency in key discussions at the HHS, White House, and congressional levels. “There’s not a voice in the room…that is designated to be the leader,” she said.

However, HHS spokesman Andrew Nixon refuted claims of a leadership vacuum, stating that the CDC is undergoing a “necessary reset” to restore trust and strengthen its core mission.

What Comes Next: A Path Forward

The White House has not yet announced a timeline for nominating a permanent CDC director. Lawrence O. Gostin, JD, professor and founding director of the O’Neill Institute for National and Global Health Law at Georgetown, expressed skepticism about the administration’s urgency in filling the position. “Unless Congress or the courts push back, I don’t feel Secretary Kennedy will be in any hurry to ensure a permanent director,” he said.

The process of securing Senate confirmation will likely be challenging, given the political climate and the scrutiny surrounding recent changes at the CDC. The Senate Committee on Health, Education, Labor and Pensions (HELP), chaired by Senator Bill Cassidy, will play a crucial role in vetting potential nominees.

For now, the CDC continues to operate under the leadership of Bhattacharya, navigating ongoing public health challenges while awaiting a permanent director. The agency’s ability to effectively respond to future threats will depend, in part, on resolving the current leadership uncertainty and restoring confidence in its scientific independence, and expertise.